Groowe Groowe / Newsroom / BIIB
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BIIB News

Biogen Inc. Common Stock

Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease

globenewswire.com
BIIB

The Inner Circle acknowledges Ilene Fennoy, MD, MPH as a Pinnacle Professional Member Inner Circle of Excellence

prnewswire.com
COLB SNY BMY PFE MRK JNJ ABBV GILD AMGN REGN BIIB CRSP VRTX MDLZ KHC PEP KO SBUX MCD YUM CMG TSLA NVDA GOOG MSFT AMZN META IBM ORCL CSCO ADBE CRM INTC AMD QCOM MU SMCI ACN NOW PANW SNPS CDNS MRVL LRCX KLAC ASML AMAT NXPI ON INFY WMT COST HD LOW TGT BBY MGM LVS WYNN MAR HPE HPQ DELL XRX GE BA LMT RTX GD NOC CAT DE HON MMM AXP V MA JPM BAC WFC GS MS DIS CMCSA NFLX T VZ CHTR TMUS XOM CVX SHEL BABA JD PDD NTES BIDU IQ BILI EDU RLX LI XPEV NIO CPT M KSS ROST TJX URBN PVH RL AEO ANF LULU UA NKE CROX EAT SJM GIS ADM IFF CPB KDP MNST STZ CCEP BUD MOLN CRBU EDIT NTLA BEAM ALNY AZN BNTX MRNA XBIT RBLX EXAS CRWD FTNT OKTA DDOG SNOW PLTR AI UPST PYPL COIN MARA CLSK RIOT BTBT MSTR

AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer

globenewswire.com
BIIB VRTX BMY

CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities

globenewswire.com
MRNA BIIB

Patient Safety Launches Nationwide

prnewswire.com
MSFT UNH HCA AMZN CVS GEHC BIO MDLZ SYK BMY PFE JNJ ABBV AMGN GILD REGN BIIB MRNA BNTX XRAY ISRG TMDX HOLX EW COO LH DGX CTAS BRKR VRTX ALGN MDT BAX ZBH VRSN ADBE IBM ORCL HPQ DELL CSCO INTC QCOM MU AMAT LRCX KLAC ADI NXPI MCHP ON NVDA AMD GOOG META AAPL AVGO TSLA

Leqembi® Iqlik™ PDUFA date updated to August 24 in the U.S.

prnewswire.com
BIIB

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease

prnewswire.com
BIIB

Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease

globenewswire.com
BIIB

InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China

globenewswire.com
BIIB

Form 8-K

sec.gov
STOK BIIB